Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

489-513 (Activation loop from InterPro)

Target domain

347-625 (Protein kinase domain)

Relief mechanism

Assay

Autoinhibited structure

Activated structure

1 structures for Q9M345

Entry ID Method Resolution Chain Position Source
AF-Q9M345-F1 Predicted AlphaFoldDB

35 variants for Q9M345

Variant ID(s) Position Change Description Diseaes Association Provenance
tmp_3_19935173_A_C 5 L>R No 1000Genomes
ENSVATH02501581 12 F>S No 1000Genomes
tmp_3_19935134_A_T 18 M>K No 1000Genomes
tmp_3_19935128_G_A 20 S>F No 1000Genomes
ENSVATH14430547 24 N>T No 1000Genomes
tmp_3_19935042_G_T 49 P>T No 1000Genomes
tmp_3_19935038_T_C 50 N>S No 1000Genomes
ENSVATH02501579 60 V>L No 1000Genomes
ENSVATH00418092 68 C>Y No 1000Genomes
ENSVATH12748183 73 R>Q No 1000Genomes
tmp_3_19934955_G_C 78 Q>E No 1000Genomes
tmp_3_19934951_T_C 79 N>S No 1000Genomes
ENSVATH06310115 105 I>F No 1000Genomes
ENSVATH06310114 110 A>T No 1000Genomes
tmp_3_19934729_C_T 153 G>E No 1000Genomes
tmp_3_19934583_C_T 202 D>N No 1000Genomes
ENSVATH14430523 267 A>P No 1000Genomes
ENSVATH06310110 273 S>W No 1000Genomes
tmp_3_19934361_G_A 276 P>S No 1000Genomes
tmp_3_19934252_A_G 312 I>T No 1000Genomes
tmp_3_19934085_T_A 368 T>S No 1000Genomes
ENSVATH02501574 448 T>K No 1000Genomes
tmp_3_19933707_C_T 494 A>T No 1000Genomes
ENSVATH00418088 528 T>A No 1000Genomes
tmp_3_19933536_G_A 551 H>Y No 1000Genomes
tmp_3_19933478_C_T 570 R>K No 1000Genomes
tmp_3_19933400_T_A 596 K>I No 1000Genomes
tmp_3_19933395_C_T 598 G>S No 1000Genomes
tmp_3_19933382_G_A 602 S>L No 1000Genomes
tmp_3_19933326_C_T 621 G>R No 1000Genomes
tmp_3_19933311_G_C 626 P>A No 1000Genomes
ENSVATH06310103 633 L>M No 1000Genomes
ENSVATH06310102 635 A>G No 1000Genomes
tmp_3_19933251_C_T 646 G>S No 1000Genomes
ENSVATH06310100 647 F>C No 1000Genomes

2 associated diseases with Q9M345

[MIM: 242860]: Immunodeficiency-centromeric instability-facial anomalies syndrome 1 (ICF1)

A rare disorder characterized by a variable immunodeficiency resulting in recurrent infections, facial anomalies, and branching of chromosomes 1, 9, and 16. Other variable symptoms include growth retardation, failure to thrive, and psychomotor retardation. Laboratory studies show limited hypomethylation of DNA in a small fraction of the genome in some, but not all, patients. . Note=The disease is caused by variants affecting the gene represented in this entry.

[MIM: 619478]: Facioscapulohumeral muscular dystrophy 4, digenic (FSHD4)

A digenic form of facioscapulohumeral muscular dystrophy, a degenerative muscle disease characterized by slowly progressive weakness of the muscles of the face, upper-arm, and shoulder girdle. With disease progression, other muscles may also become affected. There is significant clinical variability and incomplete penetrance. . Note=The disease is caused by variants affecting distinct genetic loci, including the gene represented in this entry. DNMT3B mutations lead to DUX4 expression in somatic tissues, including muscle cells, when an haplotype on chromosome 4 is permissive for DUX4 expression. Ectopic expression of DUX4 in skeletal muscle activates the expression of stem cell and germline genes, and, when overexpressed in somatic cells, DUX4 can ultimately lead to cell death. .

Without disease ID
  • A rare disorder characterized by a variable immunodeficiency resulting in recurrent infections, facial anomalies, and branching of chromosomes 1, 9, and 16. Other variable symptoms include growth retardation, failure to thrive, and psychomotor retardation. Laboratory studies show limited hypomethylation of DNA in a small fraction of the genome in some, but not all, patients. . Note=The disease is caused by variants affecting the gene represented in this entry.
  • A digenic form of facioscapulohumeral muscular dystrophy, a degenerative muscle disease characterized by slowly progressive weakness of the muscles of the face, upper-arm, and shoulder girdle. With disease progression, other muscles may also become affected. There is significant clinical variability and incomplete penetrance. . Note=The disease is caused by variants affecting distinct genetic loci, including the gene represented in this entry. DNMT3B mutations lead to DUX4 expression in somatic tissues, including muscle cells, when an haplotype on chromosome 4 is permissive for DUX4 expression. Ectopic expression of DUX4 in skeletal muscle activates the expression of stem cell and germline genes, and, when overexpressed in somatic cells, DUX4 can ultimately lead to cell death. .

15 regional properties for Q9M345

Type Name Position InterPro Accession
domain Sema domain 20 - 509 IPR001627
repeat Plexin repeat 511 - 552 IPR002165-1
repeat Plexin repeat 658 - 701 IPR002165-2
repeat Plexin repeat 807 - 851 IPR002165-3
domain IPT domain 860 - 955 IPR002909-1
domain IPT domain 956 - 1041 IPR002909-2
domain IPT domain 1043 - 1143 IPR002909-3
domain IPT domain 1145 - 1240 IPR002909-4
domain Plexin, cytoplasmic RasGAP domain 1315 - 1862 IPR013548
domain PSI domain 511 - 561 IPR016201-1
domain PSI domain 658 - 705 IPR016201-2
domain PSI domain 806 - 859 IPR016201-3
domain Plexin, TIG domain 1 566 - 657 IPR041019
domain Plexin, TIG domain 2 712 - 805 IPR041362
domain Plexin, cytoplasmic RhoGTPase-binding domain 1484 - 1596 IPR046800

Functions

Description
EC Number 2.7.11.1 Protein-serine/threonine kinases
Subcellular Localization
  • Cell membrane ; Single-pass type I membrane protein
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

3 GO annotations of cellular component

Name Definition
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
integral component of membrane The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

4 GO annotations of molecular function

Name Definition
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
carbohydrate binding Binding to a carbohydrate, which includes monosaccharides, oligosaccharides and polysaccharides as well as substances derived from monosaccharides by reduction of the carbonyl group (alditols), by oxidation of one or more hydroxy groups to afford the corresponding aldehydes, ketones, or carboxylic acids, or by replacement of one or more hydroxy group(s) by a hydrogen atom. Cyclitols are generally not regarded as carbohydrates.
protein serine kinase activity Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate.
transmembrane receptor protein serine/threonine kinase activity Combining with a signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction: ATP protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.

4 GO annotations of biological process

Name Definition
defense response to bacterium Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism.
defense response to oomycetes Reactions triggered in response to the presence of oomycetes that act to protect the cell or organism.
pollen development The process whose specific outcome is the progression of the pollen grain over time, from its formation to the mature structure. The process begins with the meiosis of the microsporocyte to form four haploid microspores. The nucleus of each microspore then divides by mitosis to form a two-celled organism, the pollen grain, that contains a tube cell as well as a smaller generative cell. The pollen grain is surrounded by an elaborate cell wall. In some species, the generative cell immediately divides again to give a pair of sperm cells. In most flowering plants, however this division takes place later, in the tube that develops when a pollen grain germinates.
protein phosphorylation The process of introducing a phosphate group on to a protein.

20 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
P46197 NPR2 Atrial natriuretic peptide receptor 2 Bos taurus (Bovine) PR
Q24488 Ror Tyrosine-protein kinase transmembrane receptor Ror Drosophila melanogaster (Fruit fly) SS
Q9V6K3 Nrk Tyrosine-protein kinase transmembrane receptor Ror2 Drosophila melanogaster (Fruit fly) SS
Q96S53 TESK2 Dual specificity testis-specific protein kinase 2 Homo sapiens (Human) PR
Q06806 Tie1 Tyrosine-protein kinase receptor Tie-1 Mus musculus (Mouse) SS
Q02858 Tek Angiopoietin-1 receptor Mus musculus (Mouse) SS
O08680 Epha3 Ephrin type-A receptor 3 Rattus norvegicus (Rat) SS
P54757 Epha5 Ephrin type-A receptor 5 Rattus norvegicus (Rat) SS
P54759 Epha7 Ephrin type-A receptor 7 Rattus norvegicus (Rat) SS
P09759 Ephb1 Ephrin type-B receptor 1 Rattus norvegicus (Rat) SS
P0C0K7 Ephb6 Ephrin type-B receptor 6 Rattus norvegicus (Rat) SS
O80939 LECRK41 L-type lectin-domain containing receptor kinase IV.1 Arabidopsis thaliana (Mouse-ear cress) PR
O81291 LECRK44 L-type lectin-domain containing receptor kinase IV.4 Arabidopsis thaliana (Mouse-ear cress) PR
O81292 LECRK43 L-type lectin-domain containing receptor kinase IV.3 Arabidopsis thaliana (Mouse-ear cress) PR
Q9M1G4 LECRK15 Probable L-type lectin-domain containing receptor kinase I.5 Arabidopsis thaliana (Mouse-ear cress) PR
Q9STF0 LECRKS3 Receptor like protein kinase S.3 Arabidopsis thaliana (Mouse-ear cress) PR
Q9M2S4 LECRKS4 L-type lectin-domain containing receptor kinase S.4 Arabidopsis thaliana (Mouse-ear cress) PR
Q96285 LECRK55 L-type lectin-domain containing receptor kinase V.5 Arabidopsis thaliana (Mouse-ear cress) PR
Q9FG33 LECRKS5 Probable L-type lectin-domain containing receptor kinase S.5 Arabidopsis thaliana (Mouse-ear cress) PR
Q9LSR8 LECRK19 L-type lectin-domain containing receptor kinase I.9 Arabidopsis thaliana (Mouse-ear cress) PR
10 20 30 40 50 60
MFVKLKLIFF FFLLCQIMIS SSQNLNFTYN GFHPPLTDIS LQGLATVTPN GLLKLTNTSV
70 80 90 100 110 120
QKTGHAFCTE RIRFKDSQNG NVSSFSTTFV FAIHSQIPTL SGHGIAFVVA PTLGLPFALP
130 140 150 160 170 180
SQYIGLFNIS NNGNDTNHIF AVEFDTIQSS EFGDPNDNHV GIDLNGLRSA NYSTAGYRDD
190 200 210 220 230 240
HDKFQNLSLI SRKRIQVWID YDNRSHRIDV TVAPFDSDKP RKPLVSYVRD LSSILLEDMY
250 260 270 280 290 300
VGFSSATGSV LSEHFLVGWS FRLNGEAPML SLSKLPKLPR FEPRRISEFY KIGMPLISLS
310 320 330 340 350 360
LIFSIIFLAF YIVRRKKKYE EELDDWETEF GKNRFRFKEL YHATKGFKEK DLLGSGGFGR
370 380 390 400 410 420
VYRGILPTTK LEVAVKRVSH DSKQGMKEFV AEIVSIGRMS HRNLVPLLGY CRRRGELLLV
430 440 450 460 470 480
YDYMPNGSLD KYLYNNPETT LDWKQRSTII KGVASGLFYL HEEWEQVVIH RDVKASNVLL
490 500 510 520 530 540
DADFNGRLGD FGLARLYDHG SDPQTTHVVG TLGYLAPEHS RTGRATTTTD VYAFGAFLLE
550 560 570 580 590 600
VVSGRRPIEF HSASDDTFLL VEWVFSLWLR GNIMEAKDPK LGSSGYDLEE VEMVLKLGLL
610 620 630 640 650 660
CSHSDPRARP SMRQVLQYLR GDMALPELTP LDLSAGSVMN LGGRDGFSGI AMTDFSTVFK
670
GFTGGSSIAD SLLSGGR